1. Home
  2. SIF vs IMUX Comparison

SIF vs IMUX Comparison

Compare SIF & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SIFCO Industries Inc.

SIF

SIFCO Industries Inc.

HOLD

Current Price

$13.24

Market Cap

80.2M

Sector

Industrials

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$1.16

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIF
IMUX
Founded
1913
2016
Country
United States
United States
Employees
N/A
66
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.2M
75.2M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
SIF
IMUX
Price
$13.24
$1.16
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$4.80
AVG Volume (30 Days)
76.8K
2.6M
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
86.67
38.00
EPS
0.29
N/A
Revenue
$111,212,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$43.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.33
$0.51
52 Week High
$16.19
$1.51

Technical Indicators

Market Signals
Indicator
SIF
IMUX
Relative Strength Index (RSI) 50.87 52.64
Support Level $12.51 $0.62
Resistance Level $16.19 $1.17
Average True Range (ATR) 1.36 0.11
MACD -0.35 -0.03
Stochastic Oscillator 27.62 35.14

Price Performance

Historical Comparison
SIF
IMUX

About SIF SIFCO Industries Inc.

SIFCO Industries Inc produces forgings, sub-assemblies, and machined components for the Aerospace and Energy markets. Its services include forging, heat treating, machining, surface treatment, non-destructive testing, and sub-assembly of forged components. The company manufactures envelopes and precision forgings, as well as rough and finished machined parts, serving OEMs, Tier 1 and Tier 2 suppliers, and aftermarket providers across Aerospace, Defense, Energy, and Commercial Space. Its Products are made from steel, high-temperature alloys, nickel alloys, titanium, and aluminum, and include components for aircraft and industrial gas turbine engines, airframe structures, landing gear, wheels and brakes, helicopter rotating parts, and other commercial and industrial applications.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: